Direct conversion from long‐acting testosterone replacement therapy to Natesto allows for spermatogenesis resumption: Proof of concept

Long‐acting testosterone replacement therapy (TRT) suppresses spermatogenesis. A short‐acting TRT, Natesto, maintains spermatogenesis in some men. This study evaluated hormonal and semen parameters converting men from long‐acting TRT to Natesto. Baseline hormones, again on long‐acting TRT and 1 mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavoussi, Parviz K., Machen, Graham L., Chen, Shu‐Hung, Gilkey, Melissa S., Chen, Justin, Hamzeh, Yazan, Aston, Kenneth I., Kavoussi, Shahryar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542608/
https://www.ncbi.nlm.nih.gov/pubmed/35521891
http://dx.doi.org/10.1111/and.14453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542608/
https://www.ncbi.nlm.nih.gov/pubmed/35521891
http://dx.doi.org/10.1111/and.14453

Ejemplares similares